IP Library › Granted Patent US 8,222,399
Granted Patent B2
US 8,222,399 · App. 11/162,597 · Granted Jul 17, 2012

Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide

Assignee: Seikagaku Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,222,399
App. No.
11/162,597
Granted
Jul 17, 2012
Kind
B2
Abstract

A photoreactive polysaccharide which comprises a polysaccharide bound to a glycidyl ester via a covalent bond, a photocrosslinked-polysaccharide prepared by using the photoreactive polysaccharide, and medical products comprising the photocrosslinked-polysaccharide.

Claims (24)

1. A photoreactive polysaccharide comprising:

a polysaccharide covalently bonded to a glycidyl ester represented by the formula (1) by opening the epoxy group:

wherein

represents a residue of a photoreactive compound having the carboxyl group identified, and an unsaturated carbon double bond;

and wherein the polysaccharide is a hyaluronic acid; and,

a photoreactive compound is selected from the group consisting of: cinnamic acid, thiopheneacrylic acid and cinnamilideneacetic acid.

2. The photoreactive polysaccharide according to claim 1 , wherein the photoreactive compound is cinnamic acid.

3. The photoreactive polysaccharide of claim 1 wherein the polysaccharide is covalently bonded to the glycidyl ester by an ester bond to a carboxyl group of the polysaccharide.

4. A photocrosslinked-polysaccharide produced by crosslinking the photoreactive polysaccharide according to claim 1 .

5. A photocrosslinked-polysaccharide produced by crosslinking the photoreactive polysaccharide according to claim 2 .

6. A photocrosslinked-polysaccharide produced by crosslinking the photoreactive polysaccharide according to claim 3 .

7. A photocrosslinked-polysaccharide in a gel state produced by irradiating a solution of the photoreactive polysaccharide according to claims 1 with light.

8. A photocrosslinked-polysaccharide in a sponge state produced by freezing or freeze-drying a solution of the photoreactive polysaccharide according to claim 1 , and irradiating the resulting frozen solution or freeze-dried product with light.

9. A photocrosslinked-polysaccharide having both properties of a gel-state product and a sponge-state product produced by: (a) irradiating a solution of the photoreactive polysaccharide according to claim 1 with light to obtain a gel-state product; freezing the gel-state product; and, irradiating the frozen gel-state product with light while keeping the frozen state; or, (b) irradiating a solution of the photoreactive polysaccharide according to claim 1 with light to obtain a gel-state product; freeze-drying the gel-state product; and, irradiating the freeze-dried gel state product with light.

10. A photocrosslinked-polysaccharide in the state of a film produced by drying a solution of the photoreactive polysaccharide according to claim 1 to obtain a film thereof, and irradiating the film with light.

11. A photocrosslinked-polysaccharide produced by the steps comprising:

irradiating a solution of the photoreactive polysaccharide according to claim 1 with light to obtain a gel-state product;

freezing the gel-state product;

irradiating the frozen gel-state product with light while keeping the frozen state to obtain a composition with both properties of gel-state product and sponge-state product; and,

drying the composition, and irradiating the composition thus dried with light.

12. A medical product which comprises the photocrosslinked-polysaccharide according to any one of claims 4 to 11 .

13. The medical product according to claim 12 , which is an antiadhesive agent.

14. The medical product according to claim 12 , which is a substrate for sustained drug release.

15. The medical product according to claim 12 , which is a substrate for culturing cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2005
From: SATO, TOMOYA
To: SEIKAGAKU CORPORATION
Reel/Frame 017253/0427 →
Priority Claims (1)
JP 2004-268145 · Sep 15, 2004 · national
Continuity (1)
Related Publication 20060057098A1 · Mar 16, 2006